Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 730 of 6351
-
New RSV vaccine shows promise for seniors in china
Vaccine CompletedThe purpose of the current study is to evaluate the immune response of the RSVPreF3 OA investigational vaccine in older adults (OA) at least (\>=) 60 years of age (YOA) in China compared to OA in the same age range to be enrolled from overseas countries that participated in the R…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 12:35 UTC
-
New CLL trial aims to reduce Life-Threatening side effect of cancer drugs
Disease control Recruiting nowChronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess the safety of venetoclax in combination with obinutuzumab or acalabrutinib in the treatment of CLL. Adverse events and change in disease activity will be…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could High-Dose vitamin D3 shield pregnant women from preeclampsia?
Prevention Recruiting nowThis study is a randomized controlled trial with two parallel groups connected at Al-Thawra Modern General Hospital in Sana'a, Yemen. It aims to compara the effect of two different vitamin D3 supplementation regimens during pregnancy on the risk of pre-eclampsia among women with…
Sponsor: Sana'a University • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
New machine keeps donor hearts alive for transplant
Disease control OngoingThe purpose of the clinical investigation is to support the use of direct procurement of donor hearts in donation after circulatory death followed by hypothermic oxygenated perfusion using the XVIVO Heart Assist Transport System. Thereby increasing the utilization of DCD donor he…
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a drug duo tame Triple-Negative breast cancer?
Disease control Recruiting nowThis phase II study is a clinical study to explore the efficacy and safety of BL-B01D1 combined with PD-1 monoclonal antibody in patients with unresectable locally advanced or recurrent metastatic triple-negative breast cancer.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
C-Section babies may get a microbial boost from mom
Disease control Recruiting nowThis study aims to develop a therapy for restoring the gut microbiome in infants born via CS. The Study will conduct a randomized, placebo-controlled feasibility trial to assess the ability of microbiome restoration by FMT and FVT in infants born by cesarean section.
Phase 1 • Sponsor: Jakob Stokholm • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New lattice radiation aims to shrink bulky tumors and ease pain
Symptom relief Recruiting nowThe purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current standard of care radiotherapy.
Phase 2 • Sponsor: University of Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Gene therapy for radiation dry mouth tracked long-term
Disease control By invitation onlyThis study will assess the long-term safety and efficacy of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.
Phase 2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a texted story boost flu shots for black kids?
Prevention Stopped earlyWhile the COVID-19 pandemic has highlighted health disparities, Black children have unduly suffered and died from seasonal influenza for decades. Through sustained partnership with Black community stakeholders, novel community-engaged research methods, and an innovative intervent…
Sponsor: Denver Health and Hospital Authority • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat blood cancers
Disease control Recruiting nowThis phase Ib/II trial tests the best dose of axatilimab and effectiveness of axatilimab with or without azacitidine for the treatment of patients with advanced phase myeloproliferative neoplasms (MPN), myeloproliferative neoplasm/myelodysplastic syndrome (MPN/MDS) overlap or hig…
Phase 1/2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New hope for teens with severe eczema: drug trial shows promise
Disease control OngoingThis is a multi-center, single arm, open label phase 3 study to evaluate the safety and efficacy of CM310 in children patients with moderate-to-severe atopic dermatitis.
Phase 3 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for lung cancer patients with brain spread: targeted pill under study
Disease control OngoingThis study is an investigator-initiated, prospective, open-label, single-arm, multicenter clinical trial aimed at exploring the antitumor activity of Lorlatinib in ALK-positive NSCLC patients with brain/ leptomeningeal metastases.
Phase 4 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a quick switch to stronger meds change schizophrenia care?
Disease control Recruiting nowSchizophrenia (SZ) affects approximately 4.5 million people across the European Union (EU) and is associated with annual healthcare and societal costs of 29 billion Euros. The impact on the daily life of patients is huge, ranging from frequent relapses and hospitalisations, the i…
Phase 4 • Sponsor: Dr. Inge Winter • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo aims to outsmart Hard-to-Treat cancers
Disease control OngoingThis phase II ComboMATCH treatment trial tests how well AMG 510 (sotorasib) with or without panitumumab works in treating patients with KRAS G12C mutant solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (adva…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThe goal of this Phase I/II, single arm, prospective, open label, dose escalation trial is to assess safety, feasibility and efficacy of ex vivo expanded autologous T cells genetically modified to express a T cell receptor (TCR) specific for dNPM1 peptides restricted to human leu…
Phase 1/2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Heart pouch closure may cut stroke risk in atrial fibrillation patients
Prevention Recruiting nowThe purpose of the project is to elucidate whether it is possible to identify which patients are at risk of forming blood clots that can cause stroke based on analysis of the electrocardiogram. In connection with the operation, the small pouch known as the auricle of the heart i…
Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Immunotherapy combo shows promise against tough rectal cancers
Disease control Recruiting nowColorectal cancer is a common gastrointestinal tumor, with rising incidence in China. Rectal cancer accounts for nearly half of new cases, and many patients are diagnosed at a locally advanced stage. Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment, but only 20-30% …
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 13:43 UTC
-
Can skipping opioids speed up recovery from thyroid surgery?
Symptom relief Recruiting nowTo analyze and compare the effect of OFA scheme and traditional balanced anesthesia scheme on QoR15 after thyroidectomy, and further clarify the safety and rationality of OFA scheme in perioperative application of thyroid surgery.
Phase 4 • Sponsor: Beijing Friendship Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Rewiring the brain: could neurofeedback break the loop of suicidal thoughts?
Symptom relief CompletedFew treatments target core features of suicidal thoughts and behaviors in Veterans. Real-time functional magnetic resonance imaging neurofeedback can provide information regarding brain activation associated with suicide-specific rumination, defined as a "repetitive mental fixati…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could VR worlds sharpen the aging mind? a new trial puts it to the test
Symptom relief Recruiting nowThis project will explore the feasibility and efficacy of the fully immersive virtual reality leisure cognitive training tool developed by Chang Gung University in patients with mild to moderate dementia. The feasibility study will assess the feasibility and emotion-related indic…
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC